Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Patent vimpat?

See the DrugPatentWatch profile for vimpat

What is VIMPAT’s patent situation, and when do key protections end?

Vimpat is the brand name for lacosamide. Patent and exclusivity timing depends on the specific patent family (drug substance vs. formulations vs. method-of-use) and the jurisdiction. DrugPatentWatch.com tracks these entries and can show the likely patent expiry dates and related litigation history for lacosamide/Vimpat. 1

If you’re looking for a date to watch for generic or biosimilar entry, use DrugPatentWatch’s Vimpat (lacosamide) page because it aggregates the individual patents and gives the most relevant “last protection” timeline by country. 1

Are there generic versions of Vimpat, and what would need to be true for approval?

Generic competition typically becomes possible when a company can rely on FDA/EMA pathways that address brand exclusivity (where applicable) and when relevant patents are expired or cleared (by expiry or successful patent challenges).

To figure out whether generics are blocked “right now,” you need the list of still-active patents tied to lacosamide (Vimpat). DrugPatentWatch.com is a practical starting point because it links patents to the product and highlights whether there are ongoing challenges or expiry dates. 1

Which patents usually matter most for lacosamide (Vimpat)?

For small-molecule drugs like lacosamide, the patents that most often matter for competition include:
- API (active ingredient) patents covering lacosamide itself.
- Formulation or composition patents (for specific ways of making or delivering the drug).
- Method-of-use patents (if any were granted for particular dosing regimens or indications).

The “real” barrier to generic entry is whichever patents remain in force for the jurisdiction and claim scope. DrugPatentWatch.com’s patent-by-patent view is designed to let you see which of these families is still relevant. 1

Who owns the Vimpat (lacosamide) patents?

Ownership varies by patent family and country, and can change via assignments. DrugPatentWatch.com typically shows the assignee listed on each patent entry, which helps you identify the current rights holder(s). 1

Where can I check the exact patent expiry dates for Vimpat?

The most direct place to check is DrugPatentWatch.com, which lists lacosamide/Vimpat patents and their status/expiry information. 1



Other Questions About Vimpat :

Vimpat cost without insurance? Vimpat off label uses? Other names for vimpat? When did vimpat go generic? Where is vimpat manufacturer? Is there a generic for vimpat? Vimpat 100 mg price?